Brainstorm Cell Therapeutics: MSC-NTF Cell Therapy Shows Mid-Stage Promise In PMS
Photo by vshivkova/iStock via Getty Images
Graphics Source: Brainstorm Cell Therapeutics, Inc.
Introduction: What is Brainstorm Cell Therapeutics?
Brainstorm Cell Therapeutics, Inc. (NASDAQ: BCLI) is a biotechnology company developing best-in-class autologous cell therapies for treating neurodegenerative diseases including Amyotrophic Lateral Sclerosis (“ALS”), Progressive Multiple Sclerosis (“PMS”), Alzheimer’s disease (“AD”), and others. This is done through the company’s proprietary NurOwn®…
